Oncology Modalities Facing Off: Room for Many or One to Rule them All?

Cancer Progress 2020
Wednesday, May 6th, 2020
5:45 – 7:00 PM

Moderator: Joel S. Sandler, PhD, Principal, Cello Health BioConsulting, previously Defined Health


  • Michael DeRidder, PhD, VP, Medicine Commercialization Leader, Oncology Cell Therapy, GSK
  • Michael Kalos, PhD, EVP and Head of R&D, Arsenal Biosciences
  • Llew Keltner, MD, PhD, CEO, EPISTAT
  • Jason B. Litten, MD, CMO, Artiva Biotherapeutics
  • Vanessa Lucey, PhD, MBA, Director, CRI Venture Fund & Clinical Accelerator, Cancer Research Institute
[ Coming Soon ]